Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6

被引:8
作者
Micic, D
Macut, D
Sumarac-Dumanovic, M
Kendereski, A
Popovic, V
Deghenghi, R
Dieguez, C
Casanueva, FF
机构
[1] Univ Santiago de Compostela, Sch Med, Dept Med, Endocrine Sect,Edocrine Unit, E-15780 Santiago De Compostela, Spain
[2] Univ Santiago de Compostela, Sch Med, Dept Physiol, Endocrine Sect, E-15780 Santiago De Compostela, Spain
[3] Univ Belgrade, Inst Endocrinol, Belgrade, Yugoslavia
[4] Europeptides, Argenteuil, France
[5] Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Santiago De Compostela, Spain
关键词
D O I
10.1530/eje.0.1470761
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: GH secretagogues and GH-releasing hormone (GHRH) exert a complex cross-talk at the somatotrope cell, and undertake homologous and heterologous desensitization. On the other hand, the discovery of ghrelin as a new factor implicated in the regulation of GH secretion makes a thorough assessment of its properties and cell biology processes mandatory. In order to implement this, three different testing schedules were devised using the administration, on the same day, of two GH stimuli administered in sequential order 120 min apart. The two aims of the study were (a) to evaluate the relative potency of ghrelin in comparison with other GH stimulants and (b) to assess the presence of homologous or heterologous desensitization between these compounds. Design: The different testing days performed in random order were (a) on one day, saline was administered at time 0 min and ghrelin at time 120 min, (b) on another testing day, GHRH was administered at 0 min followed by ghrelin at 120 min and (c) on the last testing day, GH-releasing peptide-6 (GHRP-6) and ghrelin were injected at 0 and 120 min respectively. Ghrelin, GHRH and GHRP-6 were always administered at 1 mug/kg i.v., and plasma GH was measured. Patients: Six normal subjects participated in the study after providing informed consent, and each was assessed on three different testing days, at least 1 week apart. Results: Saline did not modify peak GH (means+/-s.E.) values (1.5 +/- 0.6 mug/l), and ghrelin administered 120min later induced a significant GH rise (39.9+/-2.8mug/l). On a different testing day, GHRH induced a GH peak (9.4+/-2.8mug/l) lower than that of ghrelin injected 120min later (26.8+/- 4.7 mug/l). On the last testing day, GHRP-6 at time 0 induced a GH peak of 18.4+/-5.9 mug/l and ghrelin 120min later a peak of 19.8 +/-2.9 mug/l. The ghrelin-mediated GH secretion after GHRP-6 was significantly lower than the GH elicited by ghrelin when the preceding administration was saline. This demonstrated that ghrelin was partially affected by GHRP-6 and was not affected by GHRH. Conclusions: Calculated at equal mass doses or in molecular terms, ghrelin appears to be a more potent stimulus than GHRP-6 and GHRH. Ghrelin was completely insensitive to the previous administration of GHRH as well as relatively resistant to the homologous desensitization exerted by GHRP-6.
引用
收藏
页码:761 / 766
页数:6
相关论文
共 38 条
  • [1] Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans
    Ariyasu, H
    Takaya, K
    Tagami, T
    Ogawa, Y
    Hosoda, K
    Akamizu, T
    Suda, M
    Koh, T
    Natsui, K
    Toyooka, S
    Shirakami, G
    Usui, T
    Shimatsu, A
    Doi, K
    Hosoda, H
    Kojima, M
    Kangawa, K
    Nakao, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) : 4753 - 4758
  • [2] Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans
    Arvat, E
    Di Vito, L
    Broglio, F
    Papotti, M
    Muccioli, G
    Dieguez, C
    Casanueva, FF
    Deghenghi, R
    Camanni, F
    Ghigo, E
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (08) : 493 - 495
  • [3] Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone
    Arvat, E
    Maccario, M
    Di Vito, L
    Broglio, F
    Benso, A
    Gottero, C
    Papotti, M
    Muccioli, G
    Dieguez, C
    Casanueva, FF
    Deghenghi, R
    Camanni, F
    Ghigo, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) : 1169 - 1174
  • [4] Bowers CY, 1998, GROWTH HORMONE SECRETAGOGUES IN CLINICAL PRACTICE, P1
  • [5] ON THE INVITRO AND INVIVO ACTIVITY OF A NEW SYNTHETIC HEXAPEPTIDE THAT ACTS ON THE PITUITARY TO SPECIFICALLY RELEASE GROWTH-HORMONE
    BOWERS, CY
    MOMANY, FA
    REYNOLDS, GA
    HONG, A
    [J]. ENDOCRINOLOGY, 1984, 114 (05) : 1537 - 1545
  • [6] Growth hormone secretagogues: Physiological role and clinical utility
    Casanueva, FF
    Dieguez, C
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (01) : 30 - 38
  • [7] CASANUEVA FF, 2002, IN PRESS REV ENDOCRI
  • [8] CHARRO A, 1999, REGULATION PITUITARY, P181
  • [9] A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
    Cummings, DE
    Purnell, JQ
    Frayo, RS
    Schmidova, K
    Wisse, BE
    Weigle, DS
    [J]. DIABETES, 2001, 50 (08) : 1714 - 1719
  • [10] Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats
    Date, Y
    Murakami, N
    Kojima, M
    Kuroiwa, T
    Matsukura, S
    Kangawa, K
    Nakazato, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) : 477 - 480